Beyond Compliance: Making AI Explanations Meaningful for Patients in Clinical Practice

A radiologist reviews a lung CT scan. The AI flags a nodule with an 87% malignancy probability. When the patient asks, "Why does the computer think it's cancer?" the confidence score and heat map tell her what the AI concluded—but not why. This is the explanation gap facing clinical AI.

The European Union AI Act, which entered into force in August 2024 with obligations phasing in through 2027, establishes patient rights to "clear and meaningful explanations" of AI-driven medical decisions. But the legislation cannot answer a critical question: What does a meaningful explanation actually look like in clinical practice, and how do we deliver it?

The Legal Foundation—And Its Limits

EU AI Act Requirements

Many clinically deployed medical AI systems fall into the AI Act's "high-risk" category, particularly:

Software regulated as medical devices

AI serving as safety components of regulated products

Decision support systems influencing clinical diagnosis

The Act requires deployers of high-risk AI to provide those affected with explanations of decisions shaped by these systems[^1].

GDPR and the Automation Paradox

The General Data Protection Regulation (GDPR) Article 22 provides safeguards against decisions "based solely on automated processing," including the right to meaningful information about the logic behind those decisions.

But here's the paradox: most clinical AI doesn't meet Article 22's threshold because a human clinician typically remains the formal decision maker. The human oversight meant to protect patients may also reduce their legal claim to explanation[^2].

The Result: Patients have legal grounds to seek explanations, but neither framework specifies what "meaningful" actually requires.

Three Barriers to Meaningful Explanations

Barrier 1: Technical Complexity

The most accurate AI models generate outputs through millions of interacting parameters in ways that even their developers cannot fully trace. Current explainable AI methods offer only partial solutions:

The Trade-off: Requiring greater transparency can push developers toward simpler, more interpretable models—but these often sacrifice diagnostic accuracy[^3].

Barrier 2: Clinical Implementation

Even where technical explanations exist, delivery faces practical barriers:

Clinician comprehension gap: Doctors typically receive confidence scores and recommendations, not underlying reasoning. They may be asked to explain decisions they don't fully understand themselves.

Time constraints: AI adds complexity to clinical encounters already stretched thin.

Automation bias: A prospective study of radiologists reading mammograms found that incorrect AI suggestions pulled readers toward incorrect diagnoses regardless of experience level[^4].

The Core Problem: An explanation delivered by a clinician who has already deferred to the algorithm may reflect the AI's conclusion rather than an independent clinical assessment.

Barrier 3: Patient Understanding

Here's the uncomfortable truth: even technically accurate explanations may fail patients.

Between 22% and 58% of EU citizens report difficulty accessing, understanding, appraising, and applying health information needed to navigate healthcare services. Gaps are pronounced among:

Older adults

Lower socioeconomic groups

Rural communities

Those with limited health literacy

Statistical literacy barrier: Interpreting AI outputs requires statistical and technical understanding that even high general education doesn't guarantee. Many highly educated individuals struggle with medical statistics and probability statements.

The paradox of detail: Research on medical decision-making suggests excessive technical information can cause cognitive overload—leading patients to defer to physician authority rather than engage with the explanation[^5].

What Patients Actually Need

For meaningful participation in decisions, patients typically need clarity on:

**What the system is recommending** and for which decision point

**How confident it is** and what that confidence means in practical terms

**Key limitations** such as known performance gaps in specific populations

**Viable alternative options** available to them

This reframes the goal from "technical transparency" to "decision-relevant clarity"—with effectiveness measurable by whether patients can answer these questions after an encounter.

Implementation: A Multi-Stakeholder Approach

For Developers

Design with patient input from the outset, not as an afterthought

Test comprehension with actual patients, not just legal compliance

Build explanation systems for multiple literacy levels

Include known limitations as standard output, not fine print

For Healthcare Institutions

Allocate dedicated time for AI discussions in clinical workflows

Train staff to support patients in navigating AI-driven recommendations

Establish clear protocols for when and how to explain AI involvement

Make explanation a clinical responsibility, not a compliance exercise

For Clinicians

Recognize automation bias as a real risk requiring active mitigation

Request understanding before explaining to patients

Frame AI as decision support, not decision replacement

Document when AI influenced clinical decisions and how

For Regulators and Policymakers

Move beyond "Was an explanation provided?" to "Can patients use it?"

Develop standards for explanation effectiveness, not just provision

Support health literacy initiatives targeting AI understanding

Consider mandatory performance disaggregation by demographic group

The Measurement Challenge

How do we know if an explanation was meaningful?

Process measures (current focus):

Was an explanation provided?

Was the required information included?

Was it documented?

Outcome measures (needed shift):

Can the patient explain the recommendation in their own words?

Can they describe confidence levels and limitations?

Do they know their alternatives?

Can they make an informed decision based on the explanation?

A Paradigm Shift: From Compliance to Effectiveness

The EU AI Act and GDPR establish important rights. But rights without implementation mechanisms remain aspirational.

Closing the explanation gap requires shifting from:

Key Takeaways for Clinical Research

**Legal rights ≠ meaningful explanations**: Patient rights exist, but delivery mechanisms don't

**Accuracy-explainability trade-off is real**: High-performing models may be least explainable

**Clinician understanding is prerequisite**: Doctors need support to understand before explaining

**Health literacy is the bottleneck**: Even perfect explanations fail if patients can't use them

**Measurement must shift**: From "was it explained?" to "can the patient use it?"

Conclusion

The promise of AI in clinical medicine depends not just on algorithmic accuracy but on the human systems around it. The right to explanation becomes meaningful only when patients can actually use that explanation to make informed decisions about their care.

As AI systems become more prevalent in clinical practice, the research community must:

Study not just AI performance but patient comprehension

Develop validated instruments for measuring explanation effectiveness

Test interventions that improve patient understanding

Advocate for implementation standards that serve patients, not just compliance checkboxes

The goal isn't transparency for transparency's sake. It's giving patients what they need to participate meaningfully in decisions about their own bodies and health.

---

References

[^1]: European Union AI Act, Regulation (EU) 2024/1689, Article 86 (Right to explanation for high-risk AI systems).

[^2]: GDPR Article 22 and the paradox of human oversight in clinical AI decision-making. Journal of Medical Internet Research. January 2026. DOI: 10.2196/95090.

[^3]: Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nature Machine Intelligence. 2019;1(5):206-215.

[^4]: Wijnands RA, et al. Effect of artificial intelligence support on radiologists' mammography reading accuracy. JAMA Oncology. 2025.

[^5]: Peters E, et al. Numeracy and health: The intersection of risk communication and medical decision-making. Medical Decision Making. 2024.